{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:56:28Z","timestamp":1792000588399,"version":"4.4.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.pain.2005.03.033","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T09:39:48Z","timestamp":1117618788000},"page":"166-167","source":"Crossref","is-referenced-by-count":7,"title":["Botulinum toxin type A therapy for chronic tension-type headache: Fact versus fiction"],"prefix":"10.1097","volume":"116","author":[{"given":"V. K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mjd.2001.118342","article-title":"Severe, intractable headache after injection with botulinum A exotoxin: report of 5 cases.","volume":"46","author":"Alam","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R2-21-20210112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(02)00313-1","article-title":"Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.","volume":"205","author":"Blersch","year":"2002","journal-title":"J Neurol Sci"},{"key":"R3-21-20210112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"R4-21-20210112","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum toxin-A poisoning: bi-phasic switch of synaptic activity between nerve sprouts and their parent terminals.","volume":"96","author":"de Paiva","year":"1999","journal-title":"Proc Natl Acad Sci (USA)"},{"issue":"Suppl 1","key":"R5-21-20210112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1526-4610.43.7s.5.x","article-title":"Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.","volume":"43","author":"Dodick","year":"2003","journal-title":"Headache"},{"key":"R6-21-20210112","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1526-4610.2003.03115.x","article-title":"Botulinum toxin injections for headache.","volume":"43","author":"Evans","year":"2003","journal-title":"Headache"},{"key":"R8-21-20210112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00415-003-0971-x","article-title":"Botulinum toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.","volume":"250","author":"Kramer","year":"2003","journal-title":"J Neurol"},{"key":"R9-21-20210112","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1526-4610.2001.041007658.x","article-title":"Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial.","volume":"41","author":"Schmitt","year":"2001","journal-title":"Headache"},{"key":"R10-21-20210112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","article-title":"BoNTTH study group. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.","volume":"109","author":"Schulte-Mattler","year":"2004","journal-title":"Pain"},{"issue":"Suppl 1","key":"R11-21-20210112","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1526-4610.43.7s.2.x","article-title":"Neurotoxins in the neurobiology of pain.","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache"},{"issue":"Suppl 1","key":"R12-21-20210112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1526-4610.43.7s.1.x","article-title":"Botulinum toxin type A: myths, facts, and current research.","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache"},{"key":"R13-21-20210112","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment.","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"key":"R14-21-20210112","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/01.WNL.0000086374.92906.6A","article-title":"A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.","volume":"61","author":"Voller","year":"2003","journal-title":"Neurology"},{"key":"R15-21-20210112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200507000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:36:38Z","timestamp":1785854198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200507000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2005.03.033","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}